ADMINISTRATION SET,

The contract specifies the procurement of a pediatric scalp vein administration set with a 21 gauge by 0.75 inch needle, no end cap, individually packaged, disposable, and sterile, supplied in units of 200 per package. The item must have a non-extendable 36-month shelf life, with no more than four months elapsed from manufacture to delivery to the government. The product is regulated by the FDA and must be sourced exclusively from approved manufacturers, Kawasumi Laboratories America or Cardinal Health 200, LLC, both under part number DBMS-21G. Bidders must clearly identify their source and part number. Packaging must comply with commercial standards as defined in the procurement document, ensuring each unit is sealed in a protected container to prevent damage, and all shipping containers must ensure safe, cost-effective delivery to the designated destination. All markings must follow Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must include the lot or control number and date of manufacture prefixed with "MFD". Delivery is required within 84 days FOB destination to APO AP 96260-5479, with no tolerance for quantity variance. Inspection and acceptance occur at the destination, and compliance with DLA packaging, marking, and logistics directives is mandatory, including adherence to the DLA Master List of Technical and Quality Requirements.